The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation
Open accessAbstract
BACKGROUND: The incidence of stroke in patients with atrial fibrillation is greatly reduced by oral anticoagulation, with the full effect seen at international normalized ratio (INR) values of 2.0 or greater. The effect of the intensity of oral anticoagulation on the severity of atrial fibrillation-related stroke is not known but is central to the choice of the target INR. METHODS: We studied incident ischemic strokes in a cohort of 13,559 patients with nonvalvular atrial fibrillation. Strokes were identified through hospitalization data bases and validated on the basis of medical records, which also provided information on the use of warfarin or aspirin, the INR at admission, and coexisting illnesses. The severity of stroke was graded according to a modified Rankin scale. Thirty-day mortality was ascertained from hospitalization and mortality files. RESULTS: Of 596 ischemic strokes, 32 percent occurred during warfarin therapy, 27 percent during aspirin therapy, and 42 percent during neither type of therapy. Among patients who were taking warfarin, an INR of less than 2.0 at admission, as compared with an INR of 2.0 or greater, independently increased the odds of a severe stroke in a proportional-odds logistic-regression model (odds ratio, 1.9; 95 percent confidence interval, 1.1 to 3.4) across three severity categories and the risk of death within 30 days (hazard ratio, 3.4; 95 percent confidence interval, 1.1 to 10.1). An INR of 1.5 to 1.9 at admission was associated with a mortality rate similar to that for an INR of less than 1.5 (18 percent and 15 percent, respectively). The 30-day mortality rate among patients who were taking aspirin at the time of the stroke was similar to that among patients who were taking warfarin and who had an INR of less than 2.0. CONCLUSIONS: Among patients with nonvalvular atrial fibrillation, anticoagulation that results in an INR of 2.0 or greater reduces not only the frequency of ischemic stroke but also its severity and the risk of death from stroke. Our findings provide further evidence against the use of lower INR target levels in patients with atrial fibrillation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Regression Models for Ordinal Data
McCullagh, P. (1980) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1980.tb01109.x · Cited by 4,453
Chi-Square Tests with One Degree of Freedom; Extensions of the Mantel-Haenszel Procedure
Mantel, N. (1963) · Journal of the American Statistical Association · doi:10.1080/01621459.1963.10500879 · Cited by 2,897
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy
Rosendaal, F. R., Cannegieter, S. C., van der Meer, F. J. M., & Briët, E. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651587 · Cited by 2,065
Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation: A Meta-Analysis
Hart, R. G., Benavente, O., McBride, R., & Pearce, L. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-7-199910050-00003 · Cited by 1,638
Stroke Severity in Atrial Fibrillation: The Framingham Study
Lin, H.-J., Wolf, P. A., Kelly-Hayes, M., Beiser, A. S., Kase, C. S., Benjamin, E. J., & D'Agostino, R. B. (1996) · Stroke · doi:10.1161/01.str.27.10.1760 · Cited by 1,389
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary
Fuster, V., Rydén, L. E., Asinger, R. W., Cannom, D. S., Crijns, H. J., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01587-x · Cited by 1,348
Palareti, G., Leali, N., Coccheri, S., Poggi, M., Manotti, C., D'Angelo, A., Pengo, V., Erba, N., Moia, M., Ciavarella, N., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01109-9 · Cited by 1,333
Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin
Hylek, E. M., & Singer, D. E. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-11-199406010-00001 · Cited by 919
Self-citationBamford, J., Sandercock, P., Dennis, M., Burn, J., & Warlow, C. (1990) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.1.16 · Cited by 814
Hylek, E. M., Skates, S. J., Sheehan, M. A., & Singer, D. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608223350802 · Cited by 789
Self-citationLandefeld, C. S., & Goldman, L. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90564-0 · Cited by 778
van Walraven, C., Hart, R. G., Singer, D. E., Laupacis, A., Connolly, S., Petersen, P., Koudstaal, P. J., Chang, Y., & Hellemons, B. (2002) · JAMA · doi:10.1001/jama.288.19.2441 · Cited by 714
Self-citationFúster, & Westerling, R. (2001) · Circulation · Cited by 607
Committee Members, Fuster, V., Rydén, L. E., Asinger, R. W., Cannom, D. S., Crijns, H. J., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., et al. (2001) · Circulation · doi:10.1161/circ.104.17.2118 · Cited by 604
Go, A. S., Hylek, E. M., Borowsky, L. H., Phillips, K. A., Selby, J. V., & Singer, D. E. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-12-199912210-00004 · Cited by 585
Self-citation(1997) · ACC Current Journal Review · doi:10.1016/s1062-1458(97)83303-x · Cited by 539
Man-Son-Hing, M., Nichol, G., Lau, A., & Laupacis, A. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.7.677 · Cited by 538
Bleeding complications in oral anticoagulant therapy. An analysis of risk factors
van der Meer, F. J. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.13.1557 · Cited by 538
Lamassa, M., Di Carlo, A., Pracucci, G., Basile, A. M., Trefoloni, G., Vanni, P., Spolveri, S., Baruffi, M. C., Landini, G., Ghetti, A., et al. (2001) · Stroke · doi:10.1161/01.str.32.2.392 · Cited by 434
The Effect of Stroke and Stroke Prophylaxis With Aspirin or Warfarin on Quality of Life
Gage, B. F. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.16.1829 · Cited by 370
Antithrombotic Therapy in Atrial Fibrillation
Albers, G. W., Dalen, J. E., Laupacis, A., Manning, W. J., Petersen, P., & Singer, D. E. (2001) · Chest · doi:10.1378/chest.119.1_suppl.194s · Cited by 360
Self-citationGage, B. F. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530230025025 · Cited by 329
Bleeding During Antithrombotic Therapy in Patients With Atrial Fibrillation
(1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440040081009 · Cited by 283
The need for randomization in the study of intended effects
Miettinen, O. S. (1983) · Statistics in Medicine · doi:10.1002/sim.4780020222 · Cited by 277
Hart, R. G., Pearce, L. A., Miller, V. T., Anderson, D. C., Rothrock, J. F., Albers, G. W., & Nasco, E. (2000) · Cerebrovascular Diseases · doi:10.1159/000016023 · Cited by 265
Sandercock, P., Bamford, J., Dennis, M., Burn, J., Slattery, J., Jones, L., Boonyakarnkul, S., & Warlow, C. (1992) · BMJ · doi:10.1136/bmj.305.6867.1460 · Cited by 255
Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study
Longstreth, W. T., Bernick, C., Fitzpatrick, A., Cushman, M., Knepper, L., Lima, J., & Furberg, C. D. (2001) · Neurology · doi:10.1212/wnl.56.3.368 · Cited by 245
Atrial Fibrillation and Stroke: Mortality and Causes of Death After the First Acute Ischemic Stroke
Kaarisalo, M. M., Immonen-Räihä, P., Marttila, R. J., Salomaa, V., Kaarsalo, E., Salmi, K., Sarti, C., Sivenius, J., Torppa, J., & Tuomilehto, J. (1997) · Stroke · doi:10.1161/01.str.28.2.311 · Cited by 220
Thomson, R., Parkin, D., Eccles, M., Sudlow, M., & Robinson, A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)90012-6 · Cited by 179
The California Automated Mortality Linkage System (CAMLIS).
Arellano, M., Petersen, G. R., Petitti, D. B., & Smith, R. E. (1984) · American Journal of Public Health · doi:10.2105/ajph.74.12.1324 · Cited by 156
Pathogenesis of anterior circulation stroke in patients with nonvalvular atrial fibrillation
Bogousslavsky, J., van Melle, G., Regli, F., & KAPPENBERGER, L. J. (1990) · Neurology · doi:10.1212/wnl.40.7.1046 · Cited by 154
Non-rheumatic atrial fibrillation as a risk factor for stroke.
Britton, M., & Gustafsson, C. (1985) · Stroke · doi:10.1161/01.str.16.2.182 · Cited by 153
Thromboembolism in Patients With Atrial Fibrillation
Sherman, D. G., Goldman, L. E., Whiting, R. B., Jurgensen, K., Kaste, M., & Easton, J. D. (1984) · Archives of Neurology · doi:10.1001/archneur.1984.04050180030011 · Cited by 142
Evans, A., & Kalra, L. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.11.1443 · Cited by 134
Manning, W. J. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430200078011 · Cited by 129
Mortality in acute stroke with atrial fibrillation. The Italian Acute Stroke Study Group.
Candelise, L., Pinardi, G., & Morabito, A. (1991) · Stroke · doi:10.1161/01.str.22.2.169 · Cited by 111
Cost-effectiveness of Therapies for Patients With Nonvalvular Atrial Fibrillation
Eckman, M. H., Falk, R. H., & Pauker, S. G. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.15.1669 · Cited by 78
GUSTAFSSON, C., & Britton, M. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00400.x · Cited by 35
Stroke severity in patients with atrial fibrillation
Penado, S., Cano, M. P., Acha, O., Hernández, J. L., & Riancho, J. A. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01063-x · Cited by 22
Cited by
Developed with the special contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Authors/Task Force Members, Camm, A. J., Kirchhof, P., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Van Gelder, I. C., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,864
Ruff, C. T., Giugliano, R. P., Braunwald, E., Hoffman, E. B., Deenadayalu, N., Ezekowitz, M. D., Camm, A. J., Weitz, J. I., Lewis, B. S., Parkhomenko, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62343-0 · Cited by 5,051
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Metadata
- Authors
- Hylek, E. M., Go, A. S., Chang, Y., Jensvold, N. G., Henault, L. E., Selby, J. V., & Singer, D. E.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-09-11
- Volume
- 349
- Issue
- 11
- Pages
- 1019-1026
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2089534375
- Cited by
- 1,277
- References
- 43
- FWCI
- 38.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.